Brilliantly.co IG Live with Mammogen.bio
Eric Kristiansen • 2 June 2021
Mammogen is a woman-led biotechnology company and we're using data, tech, science and personal experience to shatter complacency.
Founder, Marty Keiser, and CEO, Liz Cormier-May, share their plans to create an end-to-never-end community for women with breast cancer.
NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen, a female-led predictive health company developing RNA-powered molecular diagnostics for women’s health, today appointed Elise Berman, M.D., as Chief Medical Officer. Dr. Berman brings more than two decades of leadership across breast imaging, medical affairs, and clinical development. She joins Mammogen as the company advances genTRU-breast™ through clinical validation and toward commercialization.
Mammogen has announced the successful completion of a Series A financing round of up to $30 million, marking a significant milestone in the company's mission to transform breast cancer detection through innovative blood-based diagnostics.
Renowned global builder of boards and executive teams aligns with leading women's health innovator, signaling next phase of commercial growth